Shoham J, Ben-David E, Sandbank U
Immunology. 1982 Jan;45(1):31-8.
The ultrastructural changes occurring in the medullary epithelium of the thymus of young mice, as a result of repeated injections of thymic extract, TP-1 (thymostimulin) was investigated. After daily injection of TP-1 for 3 weeks, no changes in thymus architecture could be observed by light microscopy. However, by electron microscopy, specific changes were noticed in the epithelial cells. The secretory granules became dilated and engorged; diameter of granules in normal control thymus was approximately 200-250 nm, but reached 1000 nm in treated mice. Degenerative changes appeared in some of these granules, including myelin bodies, distorted configuration and fat droplets. Signs of involution of whole cells and presence of cellular debri within macrophages were observed. Acid phosphatase staining disclosed many lysosomes containing ingested granules. No such findings were observed in control untreated mice, or in mice treated by a heart extract similarly prepared to TP-1. All these findings can be taken as ultrastructural evidence for feedback inhibition of thymic secretory activity, in analogy to the changes occurring other feedback inhibited, peptide hormone secreting glands. The data indicate that (i) the thymus respond to feedback inhibitory stimuli, as other endocrine glands do; (ii)TP-1, the thymic extract under study, contains a physiologically significant thymic hormone, which, when introduced in high doses can exert specific feedback inhibition. This can be taken as an additional, new criterion for the definition of thymic hormones.
研究了反复注射胸腺提取物TP - 1(胸腺刺激素)后幼鼠胸腺髓质上皮细胞发生的超微结构变化。每日注射TP - 1持续3周后,光镜下未观察到胸腺结构有变化。然而,通过电子显微镜观察,上皮细胞出现了特定变化。分泌颗粒扩张并充满内容物;正常对照胸腺中颗粒直径约为200 - 250纳米,但在处理过的小鼠中达到了1000纳米。其中一些颗粒出现了退行性变化,包括髓样小体、构型扭曲和脂滴。观察到了整个细胞的退化迹象以及巨噬细胞内的细胞碎片。酸性磷酸酶染色显示许多含有摄取颗粒的溶酶体。在未处理的对照小鼠或用类似TP - 1制备的心脏提取物处理的小鼠中未观察到此类发现。所有这些发现可作为胸腺分泌活动反馈抑制的超微结构证据,类似于其他受反馈抑制的肽类激素分泌腺所发生的变化。数据表明:(i)胸腺如同其他内分泌腺一样对反馈抑制性刺激有反应;(ii)所研究的胸腺提取物TP - 1含有一种具有生理意义的胸腺激素,当高剂量引入时可产生特定的反馈抑制。这可作为定义胸腺激素的一个额外的新标准。